human studies bpc 157 bpc-157 evidence safety clinical trials Here's a nice graphic on that you can hand Regeneration or Risk? A Narrative BPC-157 - 10mg

Specifically, one small in vitro experiment reported that BPC-157 may have exerted suppressive effects on skin cancer cells

Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025

Reported Side Effects (rare) Mild fatigue or dizziness Temporary headache Injection site irritation Nausea (usually mild and transient) Safety Notes Should only be sourced from pharmaceutical-grade compounding pharmacies BPC-157 is prohibited by WADA for competitive athletes How Nulevel Wellness Medspa Personalizes BPC-157 Dosage Unlike generalized online dosing charts, Nulevel Wellness Medspa in Gilbert, AZ designs personalized BPC-157 protocols under medical supervision

Regular blood tests help us see if the current dose is right

It also has not been approved by the European Medicines Agency or any other major health regulator in other countries